Alpine Immune Sciences, Inc. (ALPN)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 64.70 |
| Open | 64.67 |
| Bid | 46.55 x 200 |
| Ask | 82.77 x 200 |
| Day's range | 64.65 - 64.85 |
| 52-week range | 7.78 - 64.85 |
| Volume | |
| Avg. volume | 2,275,975 |
| Market cap | 4.25B |
| Beta (5Y monthly) | 0.97 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.64 |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 61.50 |
Business WireAlpine Immune Sciences Reports First Quarter 2024 Financial Results
SEATTLE, May 09, 2024--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today reported financial results for the first quarter ended March 31, 2024.
Insider MonkeyVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript May 6, 2024 Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.76, expectations were $4.07. Vertex Pharmaceuticals Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome […]
- Thomson Reuters StreetEvents
Q1 2024 Vertex Pharmaceuticals Inc Earnings Call
Q1 2024 Vertex Pharmaceuticals Inc Earnings Call
© 2024 Yahoo. All rights reserved.